Technologies by Andrés García
Microfluidic System Enables Scalable, High-Throughput Separation for High-Purity Human Induced Pluripotent Stem Cells (hiPSCs)
Manually reprogramming stem cells is inefficient and time-consuming
5685
Novel Hydrogels for Encapsulation, Vascularization, and Transplantation of Cells
Protein and cell therapies are limited by delivery methods
9019
Quickly and Easily Generate Designer Photopatterned Hydrogel Matrices for Complex Microfluidic Tissue/Organ-on-a-Chip Devices
Current ex vivo organoid models are unable to recapitulate spatiotemporal patterning of immune cells
8986
Efficiently Generating Complex Hydrogel Structures for Tissue/Organ-on-a-Chip Models
Faster approach cuts development time to minutes while using simple instruments
Faster approach cuts development time to minutes while using simple instruments
8838, 8839
Simulated Synovial Fluid Offers Potential for Effective Treatment of Knee Osteoarthritis
Knee Osteoarthritis Difficult to Treat Despite High Prevalence
Knee Osteoarthritis Difficult to Treat Despite High Prevalence
8956
Synthetic Hydrogel for Satellite Cell Delivery in Dystrophic Skeletal Muscle
Current clinical interventions do not regenerate muscle tissue due to aging, trauma, and dystrophic disease
Current clinical interventions do not regenerate muscle tissue due to aging, trauma, and dystrophic disease
7841
Synthetic Hydrogels for Human Organoid (HO) Generation and Transplantation
Current HOs rely on tumor-derived extracellular matrices that limit their use in regenerative and translational medicine
Current HOs rely on tumor-derived extracellular matrices that limit their use in regenerative and translational medicine
7536
Hydrogels for Controlled Delivery of Lysostaphin to Treat Staphylococcus aureus Infections
Orthopedic hardware infections lack effective treatment options
Orthopedic hardware infections lack effective treatment options
7729
Developing Tumor Immune Microenvironments via Engineered Hydrogel
A biomaterial-programmed method for preclinical in vivo cancer immunotherapy evaluation
A biomaterial-programmed method for preclinical in vivo cancer immunotherapy evaluation
8785
High-Throughput MSC Potency Assay to Bring Feasibility to Immune/Inflammatory Therapeutics
Breaking barriers that have limited the approval of human mesenchymal stromal cells (MSC) as a therapeutic application by refining quality control (QC) measures
Breaking barriers that have limited the approval of human mesenchymal stromal cells (MSC) as a therapeutic application by refining quality control (QC) measures
8722
Biomolecular Coating for Implants
Biological protein ligands that recapitulate the structure of natural proteins and convey integrin receptor specificity
Biological protein ligands that recapitulate the structure of natural proteins and convey integrin receptor specificity
3967
Microfluidic Droplet for Drug Delivery and Therapeutic Applications
A hydrogel microspheres using biocompatible synthetic material that can encapsulate viable cells and bioactive molecules using a novel microfluidic droplet system
A hydrogel microspheres using biocompatible synthetic material that can encapsulate viable cells and bioactive molecules using a novel microfluidic droplet system
6467